AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,204,000 | +28.0% | 341,000 | +4.2% | 0.03% | +12.0% |
Q2 2020 | $2,504,000 | +72.3% | 327,400 | +39.2% | 0.02% | +19.0% |
Q1 2020 | $1,453,000 | -54.2% | 235,200 | -9.7% | 0.02% | -43.2% |
Q4 2019 | $3,171,000 | -35.4% | 260,600 | -38.7% | 0.04% | -40.3% |
Q3 2019 | $4,906,000 | +245.0% | 424,800 | +198.3% | 0.06% | +226.3% |
Q2 2019 | $1,422,000 | +307.4% | 142,400 | +425.5% | 0.02% | +280.0% |
Q1 2019 | $349,000 | -89.2% | 27,100 | -83.2% | 0.01% | -86.5% |
Q3 2018 | $3,222,000 | -11.4% | 161,100 | -13.6% | 0.04% | -21.3% |
Q2 2018 | $3,636,000 | +38.8% | 186,500 | +43.5% | 0.05% | +38.2% |
Q1 2018 | $2,619,000 | +52.8% | 130,000 | +39.9% | 0.03% | +78.9% |
Q3 2017 | $1,714,000 | +831.5% | 92,900 | +829.0% | 0.02% | +850.0% |
Q2 2017 | $184,000 | -38.0% | 10,000 | -24.2% | 0.00% | -60.0% |
Q1 2017 | $297,000 | -59.1% | 13,200 | -36.8% | 0.01% | -44.4% |
Q4 2016 | $727,000 | +107.7% | 20,900 | +46.2% | 0.01% | +80.0% |
Q3 2016 | $350,000 | -28.9% | 14,300 | -30.6% | 0.01% | -28.6% |
Q2 2016 | $492,000 | +12200.0% | 20,600 | +58757.1% | 0.01% | – |
Q1 2016 | $4,000 | +300.0% | 35 | -30.0% | 0.00% | – |
Q4 2015 | $1,000 | – | 50 | +150.0% | 0.00% | – |
Q3 2014 | $0 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |